CLINICAL PRACTICE GUIDELINES – INASL

INDIAN NATIONAL ASSOCIATION FOR STUDY OF THE LIVER

COVID-19 GI and Liver

Wilson�s Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India.
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India- The Andaman Statements
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
Portal Cavernoma Cholangiopathy: ConsensusStatement of a Working Party of the Indian NationalAssociation for Study of the Liver [2014]
The Indian National Association for Studyof the Liver (INASL) Consensus onPrevention, Diagnosis and Managementof Hepatocellular Carcinoma in India:The Puri Recommendations [2014]
Future of therapy for Hepatitis C in India [2014]
Consensus Statement of HCV TaskForce of the Indian National Associationfor Study of the Liver (INASL). Part I:Status Report of HCV Infection in India [2014]
Consensus Statement of HCV Task Force of theIndian National Association for Study of the Liver(INASL). Part II: INASL Recommendations forManagement of HCV in India [2014]
Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver [2010]